Locations:
SearchAdvertisement
Safety considerations prevail in FDA decision on Sentinel device
Expert in mitral valve surgery, robotics and afib
An expert’s take on four trials in three minutes
Remaining the No. 1 heart program is all about the team
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Trial stopped early after evacetrapib fails to budge event rate
IN.PACT DEEP analysis yields a call to revise diagnostic guidelines
Only commonality is a need for individualized, expert care
Interim analysis from a second major trial shows success
Optimal timing still questioned
Dual heart and stem cell transplants reflect progress
Advertisement
Advertisement